SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
Partnership enables broad reach of cfDNA methylation blood tests for early cancer detection
SENS study to assess feasibility, effectiveness and family experience of introducing SMA screening into the NHS newborn screening programme
Accomplished molecular microbiologist and protein engineer takes charge of CSIR-IMTECH after serving in key scientific and regulatory leadership roles at FSSAI
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
The company will present 21 oral and poster presentations spanning investigational and approved therapies
We are building the bridge between complex molecular data and everyday clinical decisions
The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments
Fertility platform launches flagship clinic with advanced IVF tech
We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms
Subscribe To Our Newsletter & Stay Updated